Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry

BACKGROUND: Mineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. METHODS AND RESULTS: In order to better understand MRA use and subsequent outcomes, we perform...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Am Heart Assoc
मुख्य लेखकों: Fudim, Marat, Liu, Peter R., Shrader, Peter, Blanco, Rosalia G., Allen, Larry A., Fonarow, Gregg C., Gersh, Bernard J., Kowey, Peter R., Mahaffey, Kenneth W., Hylek, Elaine, Go, Alan S., Thomas, Laine, Peterson, Eric D., Piccini, Jonathan P.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: John Wiley and Sons Inc. 2018
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015424/
https://ncbi.nlm.nih.gov/pubmed/29654203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007987
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन